Jamaica Hospital Medical Center -- Department of Public Affairs -- 8900 Van Wyck Expressway Jamaica, New York 11418
For Immediate Release
Name: Michael Hinck
Jamaica Hospital Provides New and Effective Way to Treat Prostate Gland Enlargement
June 15, 2018 (Jamaica, NY) — Dr. Ricardo Ricciardi is one of the first Urologists in New York City to be recognized for his efforts in providing a new and effective way to treat Benign Prostatic Hyperplasia (BPH), a condition that affects millions of men in the United States.
BPH — also called prostate gland enlargement — is a common condition that many men experience as they get older. The prostate is a walnut-size gland that surrounds the urethra. When the prostate becomes enlarged it can lead to BPH, which can cause uncomfortable urinary symptoms, such as frequent or urgent need to urinate and increased frequency of urination at night. In addition to urinary problems, men living with BPH also experience interrupted sleep, loss of productivity, and depression. Over 40 million men in America are affected by BPH and 12 million are currently under the care of a physician for the condition.
Until recently, men living with BPH were offered two treatment options – medication or surgery. Medication is often the first-line of therapy for BPH, but relief can be inadequate and temporary. In addition, many men have reported various side effects including sexual dysfunction, dizziness and headaches. Traditionally, the alternative treatment option has been surgery, but surgical options either require cutting, heating or removing prostate tissue to open the blocked urethra. While surgery has been effective in relieving symptoms, it requires a longer recovery period and can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.
Now, Dr. Ricciardi is offering the UroLift system, an FDA cleared, revolutionary treatment that provides rapid and durable relief from urinary symptoms associated with BPH. The UroLift system works by placing small, permanent implants into the prostate to lift and hold the enlarged tissue out of the way, relieving pressure on the urethra and allowing urine to flow. There is no cutting, heating, or removal of prostate tissue. This non-invasive procedure is done in an outpatient setting under local anesthesia. Patients experience rapid improvement with minimal side effects and are able to resume their normal routines quickly and no longer require medication.
According to Dr. Ricciardi, “I am privileged to be able to offer my patients the UroLift procedure, which is truly a breakthrough in the treatment of BPH. This procedure provides so many benefits and can increase their overall quality of life without any side effects.”
Dr. Ricciardi has performed over 100 UroLift procedures and his practice has recently been named as a Center of Excellence in this form of treatment. This designation recognizes that Dr. Ricciardi has achieved the highest level of training with the UroLift System and has demonstrated a commitment to providing exemplary care to men suffering from symptoms of BPH. Less than 70 urologists in the United States have received a Center of Excellence designation and Dr. Ricciardi is the only physician in New York City to receive this honor
Jamaica Hospital Medical Center serves a population greater than 1.2 million in Queens and Eastern Brooklyn. This 408-bed medical center is an accredited community teaching hospital with a large network of community-based ambulatory care centers. JHMC offers an array of acute inpatient, rehabilitation and mental health services, and is one of the busiest Level 1 trauma centers in New York City. The hospital provides general medical, pediatric and Ob/Gyn services. Jamaica Hospital Medical Center’s mission is to serve patients and the community in a way that is second to none. For additional information, please contact Public Affairs at 718-206-6020.